Arecor Therapeutics plc (AIM: AREC)
London
· Delayed Price · Currency is GBP · Price in GBX 58.50
0.00 (0.00%)
Jan 21, 2025, 5:08 PM GMT+1
Arecor Therapeutics Market Cap
Arecor Therapeutics has a market cap or net worth of 22.09 million as of January 22, 2025. Its market cap has decreased by -57.20% in one year.
Market Cap
22.09M
Enterprise Value
19.82M
Revenue
4.90M
Ranking
n/a
PE Ratio
n/a
Stock Price
58.50
Market Cap Chart
Since June 3, 2021, Arecor Therapeutics's market cap has decreased from 66.99M to 22.09M, a decrease of -67.03%. That is a compound annual growth rate of -26.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2025 | 22.09M | -20.41% |
| Dec 31, 2024 | 27.75M | -50.35% |
| Dec 29, 2023 | 55.89M | -23.94% |
| Dec 30, 2022 | 73.48M | -34.00% |
| Dec 31, 2021 | 111.34M | 66.19% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 169.60B |
| GSK plc | 55.45B |
| Haleon | 33.80B |
| Smith & Nephew | 8.94B |
| ConvaTec Group | 4.95B |
| Hikma Pharmaceuticals | 4.63B |
| HUTCHMED (China) | 2.00B |
| Oxford Nanopore Technologies | 1.37B |